AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
The Anglo-Swedish biotech company, which is headquartered in Cambridge, England, said the "cornerstone" of the commitment would be a new multi-billion dollar facility to produce its weight management and metabolic portfolio, including its oral GLP-1 obesity pill.
The facility, planned for the Commonwealth of Virginia, is set to be AstraZeneca's largest single manufacturing investment in the world and will "leverage AI, automation and data analytics to optimize production," the company said.
The latest funding will also expand research and development and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, and create "tens of thousands of jobs," AstraZeneca added.
CEO Pascal Soriot said the commitment underpins the firm's "belief in America's innovation in biopharmaceuticals" and would support its ambition to reach $80 billion in annual revenue by 2030, half of which is expected to come from the U.S.
AstraZeneca, which made international headlines by developing one of the key Covid-19 vaccines, has long been prioritizing the U.S. market. The United States accounted for over 40% of the company's annual revenues in 2024.
In November, shortly after the U.S. presidential election, AstraZeneca announced a $3.5 billion U.S. investment. Earlier this month, The Times reported that the firm may move its listing from London to the U.S., in what analysts said would be a major blow to the U.K.'s public markets.
AstraZeneca is the most valuable business listed on London's FTSE 100. The company declined to comment on the Times report.
AstraZeneca's funding announcement follows similar moves by global pharmaceutical firms — including Novartis, Sanofi and Roche and U.S.-headquartered Eli Lilly and Johnson & Johnson — who have all vowed over recent months to ramp up their U.S. investment amid U.S. President Donald Trump's demands to reshore domestic manufacturing.
The industry is awaiting further clarity on the Trump administration's pharma tariffs, with the final outcome of a Section 232 investigation into the sector due at the end of this month. An effort to rebalance U.S. drug prices with those paid by other countries is also underway.
Trump earlier this month suggested that the industry could face levies of up to 200%, with a brief 12-18 month grace period to allow firms to relocate manufacturing stateside. However, many firms and analysts have dubbed the time frame as insufficient.
"Typically for most medicines it's a three to four year horizon. We're working very hard to accelerate that as fast as we can and demonstrate we're making the investments we have planned," Novartis CEO Vas Narasimhan said last week during an earnings call, adding that he hoped the administration would make allowances.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
19 minutes ago
- New York Post
Indonesia trade deal will remove critical-mineral export restrictions: WH
WASHINGTON — Indonesia will remove restrictions on its critical-mineral exports to the US as part of the countries' new tariff agreement, the White House revealed Tuesday. President Trump had announced last week that he would be settling for a 19% tariff rate on the world's fourth most populous country, just a week after threatening a 32% rate. In addition to agreeing to the new nearly 20% rate, Indonesia — an archipelago of more than 17,500 islands — also said OK to removing export restrictions on critical minerals and verification requirements on imports of US goods, a White House official told reporters Tuesday. Indonesia will meanwhile levy a 0% tariff on more than 99% of US goods and will eliminate nearly all trade barriers, the official said. 3 President Trump announced Indonesia will open its market up to the US in exchange for Trump imposing a 19% tariff. Getty Images At the start of his trade war announcement in April, Trump claimed that Indonesia was charging up to 64% on some US goods. 'The United States of America will now sell American Made products to Indonesia at a Tariff Rate of ZERO, while Indonesia will pay 19% on all of their products coming into the U.S.A. — The Best Market in the World!' Trump wrote on Truth Social. 'In addition, Indonesia will supply the United States with their precious Critical Minerals, as well as sign BIG Deals, worth Tens of Billions of Dollars, to purchase Boeing Aircraft, American Farm products, and American Energy,' the president said. Trump said last week that the 'biggest part of the deal' is Indonesia opening up its markets to US exports by lowering restrictions — and also by freeing up the country's copper ore exports. 'One of the things, as you know, they're known for is very high-quality copper, which we will be using,' Trump said at the time. The deal also includes provisions for Indonesia to accept imports of US vehicles built to US federal motor vehicle safety and emissions standards and 'accepting FDA certificates and prior marketing authorizations for medical devices and pharmaceuticals,' according to the White House. 3 Containers are stacked on a cargo ship at the Jakarta International Container Terminal in Tanjung Priok Port, Jakarta, earlier this month. AFP via Getty Images The US imports textiles, agricultural products and machinery from the island country. In 2022, the import numbers totaled $34.5 billion. Its top trading partners are China and the US, and the White House pointed to the population of the country — more than 280 million — as evidence of the importance of the deal. 'Indonesia is one of the largest countries in the world to represent the vast consumer markets that we want to ship to,' a Trump administration official said on a phone call with reporters. 3 Indonesian President Prabowo Subianto gestures as he speaks to the media upon arrival from his overseas trip at Halim Perdanakusuma Airbase in Jakarta, Indonesia, last week. AP The deal with Indonesia is just one of several the Trump administration has made in its ongoing global trade negotiations. Trump announced a 19% tariff agreement with the Philippines earlier Tuesday and is looking to strike more agreements before Aug. 1, when the administration has threatened to hike tariff rates on countries who haven't come to the table.
USA Today
19 minutes ago
- USA Today
US stocks end mixed as GM shares tumble and S&P 500 reaches record high
Wall Street shares ended mixed on July 22, with steep losses in General Motors and a gain in Tesla as investors focused on recent and upcoming quarterly reports and watched for signs of progress in U.S. trade discussions. GM tumbled after the automaker reported a $1 billion hit from tariffs to its quarterly results, adding more fuel to investor concerns about U.S. President Donald Trump's global trade policy. Shares of Ford Motor also fell. Tesla climbed a day before its quarterly report, while Alphabet also reporting on Wednesday, also rose. Optimism about heavy spending on artificial intelligence has underpinned a rally in Wall Street's most valuable companies, with the S&P 500 trading around record highs. "The market is consolidating recent gains and is in a bit of a holding pattern with some huge catalysts over the next week or two, including the August 1 tariff deadline and a lot of important Magnificent Seven earnings," said Ross Mayfield, an investment strategy analyst at Baird. Other Big Tech stocks lost ground, with Meta Platforms and Microsoft both closing lower. Shares of RTX dropped after the aerospace and defense giant t from Trump's trade war despite strong demand for its engines and aftermarket services. Lockheed Martin tumbled after its quarterly profit plunged by about 80%. U.S. trade policy remains a major point of uncertainty for investors and companies as Trump's self-imposed August 1 deadline for many countries to reach agreements with the White House approaches. U.S. Treasury Secretary Scott Bessent said he would meet his Chinese counterpart next week to discuss an extension to the August 12 deadline set for tariffs on imports from China. Other trade negotiations appeared stalled, with optimism for a breakthrough deal with India waning and EU officials weighing countermeasures against the United States. According to preliminary data, the S&P 500 gained 4.30 points, or 0.07%, to end at 6,309.90 points, while the Nasdaq Composite lost 81.24 points, or 0.39%, to 20,892.93. The Dow Jones Industrial Average rose 175.77 points, or 0.40%, to 44,498.84. Philip Morris slumped after reporting second-quarter revenue below expectations, as shipments of its ZYN nicotine pouches disappointed investors. Analysts on average expected S&P 500 companies to report a 7% increase in earnings for the second quarter, with technology heavyweights driving much of that gain, according to LSEG I/B/E/S. After last week's mixed economic data, traders have all but ruled out an interest-rate cut from the U.S. Federal Reserve at next week's policy meeting. They now see about a 60% chance of a reduction in September, according to the CME's FedWatch tool.
Yahoo
27 minutes ago
- Yahoo
Trump tariffs live updates: Trump unveils new details of Indonesia deal, says deal reached with Philippines
President Trump on Tuesday said the US had reached a trade deal with the Philippines, which will see the country's imports face a 19% tariff into the US. Trump said US exports will face no import tax in the Philippines as part of the deal. The White House also unveiled new details of a confirmed trade agreement with Indonesia. Yahoo Finance's Ben Werschkul reports that a 19% tariff will apply to Indonesian goods, as well as a 40% rate on any 'transhipped' goods. Officials said no tax would apply to "99%" of US imports. The deal developments come as prospects for larger pacts with India and the European Union have soured. An interim deal between the US and India before an Aug. 1 deadline looks increasingly unlikely, according to Reuters. Talks remain deadlocked due to disagreements on key agricultural and dairy products. Meanwhile, the European Union still wants a trade pact with the US, but the bloc said to be readying its counterattack as Trump plays hardball and makes a no-deal outcome more likely. EU member states are pushing for new and stringent measures to retaliate against US companies, The Wall Street Journal reported, while its officials are meeting this week to draw up a plan for reprisals. 'If they want war, they will get war,' a German official told the WSJ. Trump is reportedly pushing for higher blanket tariffs on imports from the EU, throwing a wrench in negotiations ahead of an Aug. 1 deadline for sweeping duties to take effect. He has threatened 30% tariffs on all imports. Last week, Trump said he would soon send letters to over 150 smaller US trade partners, setting blanket tariff rates for that large group. Trump has already sent letters to over 20 trade partners outlining tariffs on goods imported from their countries. Earlier in July, Trump announced a 35% tariff on Canadian goods and followed that up with promises of 30% duties on Mexico and the EU. The letters have at times upended months of careful negotiations, with Trump saying he is both open to reaching different deals but also touting his letters as "the deals" themselves. Treasury Secretary Scott Bessent on Tuesday said he expected many deals to take shape over the next several days. Read more: What Trump's tariffs mean for the economy and your wallet Here are the latest updates as the policy reverberates around the world. LIVE 1477 updates
